Heterologous prime-boost vaccination drives stromal activation and adaptive immunity against SARS-CoV-2 variants.

Front Immunol · 2025 · PMC12151836 · PMID 40503231

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

These findings suggest a robust enhancement of CD8 T cell responses, while CD4 T cell activation showed an upward trend that did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.